ONCHILLES PHARMA
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer. The company's drug selectively targets cancer cells and is non-toxic to normal cells and tissues, helping medical professionals treat cancer patients efficiently. It was founded in 2017 and is headquartered in San Diego, California.
ONCHILLES PHARMA
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.onchillespharma.com
Total Employee:
1+
Status:
Active
Total Funding:
7.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Global Site Tag Sitelinks Search Box Organization Schema
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
OncoMed Pharmaceuticals
OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.
Seneca Therapeutics
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.
TargED Biopharmaceuticals
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Founder
Investors List
LYZZ Capital
LYZZ Capital investment in Series A - Onchilles Pharma
UChicago Startup Investment Program
UChicago Startup Investment Program investment in Series A - Onchilles Pharma
The University of Chicago Innovation Fund
The University of Chicago Innovation Fund investment in Grant - Onchilles Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-26 | Onchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer |
Official Site Inspections
http://www.onchillespharma.com Semrush global rank: 4.42 M Semrush visits lastest month: 2.51 K
- Host name: 115.112.180.107.host.secureserver.net
- IP address: 107.180.112.115
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Onchilles Pharma"
Onchilles Pharma - Crunchbase Company Profile & Funding
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer. The company's drug selectively targets cancer cells and is non-toxic to …See details»
Onchilles Pharma - PitchBook
Www.onchillespharma.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 9880 Campus Point Drive; Suite 420; San Diego, CA …See details»
Onchilles Pharma - LinkedIn
Https://onchillespharma.com 15 1 Comment Like Comment Share Onchilles Pharma 2,443 followers 8mo Report this post We're unveiling at #AACR24 preclinical data on systemically delivered N17465 in an ...See details»
Onchilles Pharma - Products, Competitors, Financials, Employees ...
Headquarters Location. 9880 Campus Point Drive Suite 420. San Diego, California, 92121, United States. 202-256-4334See details»
Therapeutics that target the ELANE pathway
We are developing new pan-cancer therapeutics leveraging the ELANE pathway to selectively kill cancer cells. Our experienced team has carved a path over decades of academic and industry roles.See details»
Onchilles Pharma - Funding, Financials, Valuation & Investors
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer.See details»
Onchilles Pharma Announces Presentation of Preclinical Data for …
SAN DIEGO, March 14, 2023 – Onchilles Pharma, a private biotech company developing new cancer therapeutics that leverage myeloid biology, announced today the presentation of …See details»
Onchilles Pharma - VentureRadar
Website: http://onchillespharma.com/ Onchilles Pharma was founded on breakthrough research that was the first to describe that human neutrophils release a major ...See details»
Onchilles Pharma - Overview, News & Similar companies - ZoomInfo
Onchilles Pharma Announces Presentation of Data for N17350 Program at SITC 2023 SAN DIEGO--(BUSINESS WIRE)-- #biotech--Onchilles Pharma, a private biotech company …See details»
Onchilles Pharma - VentureRadar
Onchilles Pharma was founded on breakthrough research that was the first to describe that human neutrophils release a major anticancer protein,... ... Find out more ...See details»
Onchilles Pharma - Research and Scientific Team | The Org
The Research and Scientific Team at Onchilles Pharma is pivotal in advancing the company's innovative cancer therapies. Comprising experts in clinical and scientific research, this team …See details»
Onchilles Pharma Nominates First Drug Development Candidate …
Dec 12, 2022 SAN DIEGO--(BUSINESS WIRE)--Onchilles Pharma, a private biotech company developing new cancer therapeutics to modulate myeloid biology, announced today the …See details»
Onchilles Pharma Raises $7 Million Series A to Advance Drug …
Jun 10, 2021 Foundational research published today in Cell is the first to describe ELANE, a major anti-cancer protein released by human neutrophils that activates cell death pathways …See details»
Onchilles Pharma Appoints Christopher Twitty, Ph.D., Chief …
Oct 26, 2021 Onchilles Appoints Christopher Twitty, Ph.D., CSO, Ingrid Joseph, DVM, Ph.D., SVP, Preclinical Development and Sonia Feau, Ph.D., Director of BiologySee details»
Onchilles Pharma Job Description Job Title: Head of Clinical …
• Excellent organization skills; capable of documenting and managing complex processes in a punctual manner. • Must have demonstrated ability to work in independent manner. …See details»
Onchilles Pharma Raises $7 Million Series A to Advance Drug
Jun 10, 2021 SAN DIEGO--(BUSINESS WIRE)-- Onchilles Pharma announced today a $7 Million Series A financing from LYZZ Capital and includes a $500,000 investment from the …See details»
Onchilles Pharma Shares Promising Preclinical Data
Apr 23, 2024 WEBSITE: onchillespharma.com NOTABLE: Onchilles Pharma’s name is a mash up of oncology and Achilles because the company’s founders believe they have found …See details»
Therapeutics that target the ELANE pathway - ONCHILLES PHARMA
Please send your resume to [email protected]. We will reach out if we have an opening that fits your qualifications. We will reach out if we have an opening that fits your qualifications. …See details»
Therapeutics that target the ELANE pathway - ONCHILLES PHARMA
Dec 12, 2022 April 9, 2024 Onchilles Pharma Presents at AACR 2024 New Preclinical Data for N17350 and N17465 Demonstrating the Potential for Potent and Tumor-Selective TreatmentSee details»